Zhejiang Conba Pharmaceutical Co., Ltd. is publicly listed on the Shanghai Stock Exchange, and its official primary stock trading code is 600572. As a prominent traditional Chinese medicine and modern pharmaceutical enterprise specializing in drug discovery, clinical manufacturing, and healthcare product distribution, its equity is widely monitored by institutional healthcare investors.